Frequently Asked Questions
Please note: Local market Nom Sig approval is still needed prior to local market use. You must also verify that
AstraZeneca owns the rights to reuse these assets/components and any files that are part of them for the context, location, and duration of your intended use.
Last Edit: July 14, 2017 Page 1
Table of Contents
About Content Centre Why was Content Centre developed? Why is it beneficial?
Why should I use the materials in Content Centre?
What are the metrics for success in Content Centre?
Accessing Content Centre How do I access Content Centre?
What is the process for requesting Content Centre access for outside agencies?
How do I gain access to the security group for medical assets on Content Centre?
What measures are in place to prevent commercial teams from viewing medical assets?
Can medical affairs personnel access commercial content?
Is Content Centre available in other languages?
Asset Availability and Planning
What are Validated Assets and Non-Validated Assets?
How do I know when a new asset has reached Content Centre?
Can Non-Validated Assets be reused?
What types of assets will be available?
How can I be sure I’m accessing the most recently approved assets?
Can images be changed?
Who populates the planning calendar?
How do global teams evaluate which assets will be promoted to Content Centre?
What is the process for GPPS/GCA and their Agency of Record (AoR) to obtain Global Nominated Signatory approval?
I don’t see my brand on Content Centre. How do I find out if/when my brand will be available?
Are assets available for all local markets?
How will an asset that has been approved globally be handled though the local approval process?
Will assets be available in my language?
Frequently Asked Questions
Please note: Local market Nom Sig approval is still needed prior to local market use. You must also verify that
AstraZeneca owns the rights to reuse these assets/components and any files that are part of them for the context, location, and duration of your intended use.
Last Edit: July 14, 2017 Page 2
If I am in a local market, can I upload my asset(s) into Content Centre for reuse in other markets?
Are there any specific assets that the local agencies should search for in Content Centre before developing it themselves?
How can I get the correct material, such as high resolution graphics, that must be sent to the agency?
Does the completed Metadata Request Form (MRF) allow us to use the asset at local level with all copyrights required?
Is learning content also available on Content Centre?
Who can I contact if I cannot find the learning material I am looking for?
Can I access learning material if I have already done promotional learner training?
How are learning materials displayed on Content Centre?
How do I recognise a medical asset versus a commercial one?
Content Packs What is a Content Pack?
What is the point / benefit of a Content Pack?
What if I would like an asset that is not included in the standard Content Pack offering?
How can I influence what is offered in a Content Pack?
What does it cost?
How long does it take to prepare a Content Pack?
Are Content Packs globally approved?
Where can I look at the Content Packs that are already available?
How do I know what other Content Packs are coming?
What is the best way to localise the Content Pack assets?
Who can I talk to about working on and creating a Content Pack?
How do I access and download the Content Pack materials?
Download Logistics How long does it take to download the file?
Where do downloaded files end up?
What do I need to download? Should I include associated files or not?
Can the source file download option be made default?
Are the reference documents present on Validated Assets?
Frequently Asked Questions
Please note: Local market Nom Sig approval is still needed prior to local market use. You must also verify that
AstraZeneca owns the rights to reuse these assets/components and any files that are part of them for the context, location, and duration of your intended use.
Last Edit: July 14, 2017 Page 3
Support Who are the local Production Partners?
Is Content Centre going to make any content changes for the assets?
If the local marketing teams need help purchasing fonts, who do they reach out to?
What other services does Content Centre provide?
Training
Who do I contact if I have questions?
What training will be provided and when?
Are agencies able to register for trainings?
Are there unique trainings for promotional and learning content?
Frequently Asked Questions
Please note: Local market Nom Sig approval is still needed prior to local market use. You must also verify that
AstraZeneca owns the rights to reuse these assets/components and any files that are part of them for the context, location, and duration of your intended use.
Last Edit: July 14, 2017 Page 4
GDO Engagement Team
Regional Engagement Managers
Brazil & LatAm
SW Europe MEA, ANZ, Asia Area
NE Europe, Russia, Eurasia
China & Japan
Patricia Hamilton
Marta Matosas
Vinay Patel
Sybille Dihanich Toshiki Nakagawa
Market Delivery Leaders Global Engagement Directors
US Respiratory/
Est Brands
US Oncology
US CVMD
GPPS GPPS/
Canada
Brian
Moriarty
Mark Kurth
Lisa Britton
Nichola Menzel*
Rose Pimpinella**
* Brands supported by Nichola Menzel – BRILINTA, LYNPARZA, IRESSA, FASLODEX, TAGRISSO,
SYMBICORT, DUAKLIR / EKLIRA, DAXAS / DALIRESP
** Brands supported by Rose Pimpinella - FORXIGA, XIGDUO XR, BYDUREON, ONGLYZA, KOMBIGGLYZE
XR, QTERN, LOKELMA, Roxadustat, Durvalumab / Tremelimumab, Moxetumomab, Acalabrutinib, BEVESPI,
Benralizumab, Tralokiumab, Pearl - PT010, Anifrolumab
GDO ENGAGEMENT TEAM
Global Digital Organisation (GDO) is available to provide market level support for
localisation and translation. Please contact your Regional Engagement Manager,
Market Delivery Leader (US) or Global Engagement Director (GPPS) for information
on how to leverage these efficient, cost-effective services.
Regional Engagement Managers
Brazil & LatAm
SW Europe MEA, ANZ, Asia Area
NE Europe, Russia, Eurasia
China & Japan
Patricia Hamilton
Marta Matosas
Vinay Patel
Sybille Dihanich Toshiki Nakagawa
Frequently Asked Questions
Please note: Local market Nom Sig approval is still needed prior to local market use. You must also verify that
AstraZeneca owns the rights to reuse these assets/components and any files that are part of them for the context, location, and duration of your intended use.
Last Edit: July 14, 2017 Page 5
About Content Centre
Why was Content Centre developed? Why is it beneficial? Content Centre was created to help streamline content development across AstraZeneca. A 12-month
audit of assets revealed numerous duplications and redundancies in content. To reduce these
redundancies and provide a cost-effective way of obtaining and leveraging reusable assets, Global Digital
Organisation (GDO) launched Content Centre.
Content Center is a global capability that provides Global Portfolio and Product Strategy (GPPS)
approved content for use by local marketing companies. Content Center utilizes a global digital platform
where local marketing companies can access and download validated* content for localization and reuse.
Content Centre provides a new way of working and will function as an operational bridge between Global
teams and local marketing teams by working closely with the GDO Engagement Team to understand
local market needs. GDO will work closely with Global Product and Portfolio Strategies (GPPS), Global
Commercial Academy (GCA) and other teams to produce assets with validated content (i.e., approved by
Global Nominated Signatory with complete source files, reference lists, annotated citations, licenses, and
global rights). These globally approved assets allow the local marketing teams to more efficiently and
effectively reuse globally produced assets.
Previously only GPPS promotional materials were available as Validated Assets in Content Centre. Now,
Content Centre expanded to include Global Commercial Academy curricula and other eLearning assets
for growth and mature brands.
Why should I use the materials in Content Centre? Content Centre contains full assets with validated content ready for use. Content Centre provides complimentary assets which allow local markets the ability to easily deploy a multi-channel campaign. These complimentary assets are referred to as Content Packs. Going to Content Centre before creating new content reduces redundancies and provides a more efficient and cost-effective way of preparing an asset, obtaining local approval, and delivering to our external customers.
What are the metrics for success in Content Centre? User Satisfaction of Content
GPPS, GCA and other teams working with Content Centre
Downloads from Local Markets
Audit of reused materials
Frequently Asked Questions
Please note: Local market Nom Sig approval is still needed prior to local market use. You must also verify that
AstraZeneca owns the rights to reuse these assets/components and any files that are part of them for the context, location, and duration of your intended use.
Last Edit: July 14, 2017 Page 6
Accessing Content Centre
How do I access Content Centre? Content Centre may be accessed by going directly to the Content Centre platform or by navigating to the
Content Centre Welcome Page and using the links at the top of the page. . A job aid is also available on
the Content Centre Welcome page which provides detailed information on how to access content within
Content Centre. If you need access to Content Centre, please request via content-
What is the process for requesting Content Centre access for outside
agencies? Outside agencies must follow the Exostar process to gain access to Content Centre. The Exostar
process is as follows:
New User completes the User Request Form and sends it to [email protected].
A ticket is then created for the Exostar Team
The Exostar Team will create a profile and automated emails are sent to the User with Username,
Password & System Generated Password.
User will follow the instructions for the First Time Login and create a profile for Exostar.
Once the profile is created, Content Centre Help Desk forwards the request to the appropriate
team to activate the User in the Exostar tool. Once Exostar access is complete, Content Centre
Help Desk team will provide access to Content Centre and other tools.
User can use Exostar Username or their email address to access Tools.
How do I gain access to the security group for medical assets on Content
Centre? To gain access to Content Centre and the GMA (Global Medical Affair), security group, please email your
request to [email protected] and your request will be reviewed by the core team to
ensure proper compliance.
What measures are in place to prevent commercial teams from viewing
medical assets? Medical assets are provided with additional metadata that restricts their viewing to only those individuals
who are members of a custom security group. Access to this security group is tightly controlled and
monitored by the GMA and Content Centre teams. This is important as GMA material is not approved for
promotional use.
Can medical affairs personnel access commercial content? Yes, GMA personnel can access commercial content. However, commercial users cannot access medical
content.
Frequently Asked Questions
Please note: Local market Nom Sig approval is still needed prior to local market use. You must also verify that
AstraZeneca owns the rights to reuse these assets/components and any files that are part of them for the context, location, and duration of your intended use.
Last Edit: July 14, 2017 Page 7
Is Content Centre available in other languages? The Content Centre platform is available in English and Japanese. The language of assets in Content
Centre can vary. Validated Assets are available in English. Non-Validated Assets may be available in
additional languages.
Asset Availability and Planning
What are Validated Assets and Non-Validated Assets? Validated Assets are assets that are globally licensed and include all source files. These assets are
clearly structured for ease of reuse and are available in an editable format so that they can be easily
localised. These assets also include editable manuscripts with annotated citations. Content Centre
highlights Validated Assets more prominently to encourage local market reuse of globally validated
content. Validated Assets are clearly identified in Content Centre by a “Validated Asset” tile on the
thumbnail.
Non-Validated Assets have not been reviewed by the Content Centre team to ensure all source files are
present or globally licensed and may not be endorsed by GPPS.
How do I know when a new Validated Asset has been uploaded to Content
Centre? There are several channels used to communicate when new content is available.
1. The Content Centre Planning Calendar is updated to include a link to the asset in Content Centre.
Note: This is only available to internal users and not agencies.
2. A Promote email will be sent to local markets to inform users that a new asset has been uploaded
to Content Centre.
3. New Validated Assets are featured on the Content Centre home page, marked with a Validated
Asset icon within the thumbnail tile.
4. An email notification can be set up directly from the Content Centre. The Content Centre job aid
(on the Content Centre Welcome Page) provides instructions on how you can subscribe to email
notifications or you can open “My Profile” within Content Centre.
5. Recently uploaded Validated Assets are featured in Content Centre’s monthly newsletter, News
Flash. To be added to the distribution list, please email [email protected].
Can Non-Validated Assets be reused? Yes, a Non-Validated Asset can be reused. However, it will most likely require more effort than reusing a
Validated Asset since source files may or may not be included, licensing may not be global, and other
important information for reuse may be missing.
Non-Validated Assets are helpful when looking for inspiration or to see what other local markets have
created.
Frequently Asked Questions
Please note: Local market Nom Sig approval is still needed prior to local market use. You must also verify that
AstraZeneca owns the rights to reuse these assets/components and any files that are part of them for the context, location, and duration of your intended use.
Last Edit: July 14, 2017 Page 8
What types of assets will be available? Content Centre provides both promotional assets as well as learning assets. Brand assets that are
common across many markets, such as Core Visual Aids (CVAs), Interactive Detail Aids (iDAs), videos,
Mechanism of Action (MOA) videos, emails, and websites are some examples of promotional assets.
eLearning modules, slide decks, and assessments are some examples of learning assets. Brand assets
which are complimentary to each other are called Content Packs. This allows local markets the ability to
implement multi-channel campaigns easily.
Many of the brands also have an asset type called Branding Elements. This asset type contains logos,
Core Claims Guides, Brand Master Files, and high resolution versions of images.
How can I be sure I’m accessing the most recently approved assets? Validated Assets that appear first on brand pages as Validated Assets are the most recently approved
versions of the asset. Validated Assets have an icon underneath the thumbnail indicating that it is
validated content. Non-validated Assets do not have this indicator. When conducting a free text search,
the results show the most recently uploaded assets, therefore the Validated Asset icon is a helpful
indicator to differentiate between Validated and Non-validated assets. Local markets and local learning
managers can also check the Content Centre Planning Calendar to see when new assets are planned for
release.
Assets which were approved globally but have expired are indicated with a red exclamation point (!) in the
upper right-hand corner of the asset tile. Since all assets must be approved locally, these assets will
remain in Content Centre.
Can images be changed? A market can substitute artwork if there is not something applicable for their country. However, we
encourage local markets to consult their branding guidelines for additional guidance and check the
branding elements folder for possible additional images.
Who populates the planning calendar? The Content Centre team populates the calendar with feedback from the appropriate global team.
How do global teams evaluate which assets will be promoted to Content
Centre? GPPS in partnership with the Global Engagement Directors (GED; Rose Pimpinella for NA based GPPS
brands and Nichola Menzel for UK based GPPS brands) plan for assets being created that have potential
for reuse by local markets.
SCLA works closely with the Content Centre Planning Manager to review and promote out the curricula
to local learning managers which has the potential for reuse by local markets.
Frequently Asked Questions
Please note: Local market Nom Sig approval is still needed prior to local market use. You must also verify that
AstraZeneca owns the rights to reuse these assets/components and any files that are part of them for the context, location, and duration of your intended use.
Last Edit: July 14, 2017 Page 9
What is the process for GPPS/GDO and their Agency of Record (AoR) to
obtain Global Nominated Signatory approval? The AoR and GPPS team review the final assets produced by the Content Centre Production Partner
(CCPP) before submission to the Global Nominated Signatory for review.
For iDetails, the functional review will be done through the Veeva Sandbox. To review functional iDetails,
GPPS teams and their supporting AoRs will need access to the Global (EU) Veeva Sandbox Environment
to review the functional assets. Access can be requested by contacting IT-Service-Desk-
When an asset has been globally approved, it will still need to be locally approved once it is downloaded
to make sure that it is compliant with local standards
I don’t see my brand on Content Centre. How do I find out if/when my brand
will be available? Most brands that are supported by global teams will have content available through Content Centre over
time, including launch brands. You can check the planning calendar for information on when new brands
or assets will become available. Additionally, we invite you to check the Non-Validated Assets folder on
the Content Centre platform for potentially re-usable assets.
Are assets available for all local markets? Yes, apart from GMA assets such as Faslodex, which are only available to local market GMA teams.
However, all assets need to be approved by each local market Nominated Signatory.
How will an asset that has been approved globally be handled through the
local approval process? Once Validated Assets have been translated and localized, all assets must be submitted for local market
Nominated Signatory approval (AZAP for US market). eLearning content may not need local Nominated
Signatory approval. Please check with your compliance team if you are unsure.
Will assets be available in my language? All Validated Assets in Content Centre will be in English. However, GDO offers the opportunity for local
marketing teams to utilize preferred production suppliers for the translation of assets. Reach out to your
GDO Engagement Team for assistance in localisation.
If I am in a regional market, can I upload my asset(s) into Content Centre
for reuse in other markets? Local marketing teams should contact their respective GDO Regional Engagement Team who will work
with the Content Delivery Directors to determine if an asset should be included in Content Centre. If the
global team determines that the asset is content “rich” (containing multiple messages), has the potential
for global reuse, and therefore included in Content Centre as a Validated Asset, then Content Centre will
work with the local market and the global team to validate the content. This includes purchasing the
global rights and licenses, obtaining sources files for the local asset, and loading the asset into Content
Frequently Asked Questions
Please note: Local market Nom Sig approval is still needed prior to local market use. You must also verify that
AstraZeneca owns the rights to reuse these assets/components and any files that are part of them for the context, location, and duration of your intended use.
Last Edit: July 14, 2017 Page 10
Centre to allow other markets to reuse. Once local markets download the content and translate it, the
localised content will need to be locally approved. Only a local Nominated Signatory can approve in-
market materials.
Assets without global approval can still be uploaded into Content Centre. These assets will sit in the Non-
Validated section of Content Centre. In this case, brands should have their agencies send assets to the
Content Centre mailbox. These agencies should fill out the Non- Validated version of the MRF (available
on Content Centre) completely and provide necessary source files.
Local Learning managers can upload the localised and approved learning curricula into the Non-Validated
section of Content Centre by having their agencies send assets to the Content Centre mailbox. These
agencies should fill out the Non-Validated version of the MRF (available on Content Centre) completely
and provide necessary source files.
If the asset is not considered as a Validated Asset it may still be eligible as a Non-Validated Asset.
Are there any specific assets that the local agencies should search for in
Content Centre before developing it themselves? Local markets and local learning managers, along with their agencies, should search for assets that are
similar in type to the ones that they are creating. Agencies should also check other Validated Assets for
the same brand to see if any of the brand content can be leveraged. For instance, if content found within
an asset type (such as iDA) is deemed valuable for reuse, the content can be used for another asset type
(such as Congress materials). The same is true for elements contained within eLearnings modules. A
part of an eLearning module can be used in an iDA or congress materials as long as it is approved by the
local Nominated Signatory and unlimited rights are purchased. Most eLearnings curricula only have
limited rights purchased since they were developed originally for internal use.
How can I get the correct material, such as high resolution graphics, that
must be sent to the agency? Selecting “Yes” to the question "Include Associated Files?" during the download process will allow you to
get the fully editable source files. Validated Assets have been verified for complete source files. Non-
Validated Assets may not have complete files, so we encourage you to use the validated files as much as
possible. Selecting "No" to the question "Include Associated Files?" at download will result in the simple
download of a preview only. Source files are not included unless you choose "yes".
Does the completed Metadata Request Form (MRF) allow us to use the
asset at local level with all copyrights required? The MRF will provide details about the licensing as well as any information that the local market may
need to purchase. As far as possible, global licenses will have been obtained for promotional assets. For
eLearnings and other training assets, in most cases only global limited rights have been purchased, as
the original intent was for internal use only.
Frequently Asked Questions
Please note: Local market Nom Sig approval is still needed prior to local market use. You must also verify that
AstraZeneca owns the rights to reuse these assets/components and any files that are part of them for the context, location, and duration of your intended use.
Last Edit: July 14, 2017 Page 11
Is learning content also available on Content Centre? Both unbranded and branded learning assets are available and can be filtered by modality such as
eLearning, slide deck or assessments. Additionally, there are selling skills assets such as leadership
selling and Key Account Management assets available.
Who can I contact if I cannot find the learning material I am looking for? If you are unable to find learning material that you have been notified is on Content Centre, please
contact the Content Centre to remedy this issue. Please review the Content Centre Planning Calendar to
determine whether additional learning materials are in the planning or production phases.
Can I access learning material if I have already done Content Centre
training? If you already completed end user training and are using Content Centre for promotional material, you will
be able to view learning material. However, certain areas of the learning content are restricted based on
your role. If you are in a learning development role, you will be able to see learning assessments. If you
are in another type of role, you will not be able to access assessments.
How are learning materials displayed on Content Centre? Similar to promotional material, learning materials will be uploaded onto Content Centre in sections which
may be broken down further. When a large learning programme is added to Content Centre, it will likely
be available at the asset level that a user can go through with the assessments available separately.
Learning Managers should review the curriculum map available in the download package to ensure all
assets have been downloaded.
How do I recognise a medical asset verses a commercial one? Medical assets will have GMA flag in the upper left hand corner of the asset thumbnail. Additionally,
medical assets will be clearly shown in the title as well as having the asset type of Medical Materials.
Frequently Asked Questions
Please note: Local market Nom Sig approval is still needed prior to local market use. You must also verify that
AstraZeneca owns the rights to reuse these assets/components and any files that are part of them for the context, location, and duration of your intended use.
Last Edit: July 14, 2017 Page 12
Content Packs
What is a Content Pack? A Content Pack is a group of the most useful assets for a brand, created directly from the core story of a
content rich asset such as an iDA (interactive Detail Aid) or CVA (Core Visual Aid) (a ‘core’ or ‘parent’
asset). All assets in a Content Pack will be available in Content Centre within a very short time of the
core asset being produced.
In addition to a core asset, a Content Pack is comprised of additional asset types, such as an interactive
.pdf, HCP emails, HCP leave behinds, banners and web content to support MultiBrand.com.
A Content Pack offers our markets a broader range of consistent, globally created and approved, high
quality assets that are ready and easy to localise. This will save local teams time, money, and effort in
producing their materials.
What is the point / benefit of a Content Pack? A Content Pack saves global teams as well as local markets both time and money in the following ways:
Consistency: All assets developed follow brand guidelines and are platform and device agnostic
Supports Multi-Channel: Multiple assets based on same core story allows markets to maximize
multi-channel marketing efforts
Cost & Quality: Content Pack assets are internally created from globally approved content
Faster Time to Market: Parallel development of assets results in faster availability to local
markets
What if I would like an asset that is not included in the standard Content
Pack offering?
If you work in GPPS please contact the Global Engagement Director for your brand. They will be
delighted to talk to your team about Content Packs and share with you the asset options available. We
also encourage every GPPS team to reach out to the local markets to determine the best mix of assets
for their particular brand. We are able to offer some alternative assets to make up your Content Pack and
can therefore switch assets in and out of the pack to best suit your needs.
Alternative assets we offer are: RTE / VAE, dosing cards, reprint carriers, folders, journal ads, congress
panels, and PowerPoint presentations.
If you are in a market, please contact your GDO Regional Engagement Team contact. They will help you
with Content Packs that are already available. If you find an asset in Content Centre that is not part of a
Content Pack but is still relevant to your market, the GDO Contacts will take your feedback and use it to
help shape future Content Packs.
Frequently Asked Questions
Please note: Local market Nom Sig approval is still needed prior to local market use. You must also verify that
AstraZeneca owns the rights to reuse these assets/components and any files that are part of them for the context, location, and duration of your intended use.
Last Edit: July 14, 2017 Page 13
How can I influence what is offered in a Content Pack? Please speak to your GDO Engagement Contact. We are eager to provide a Content Pack with assets
that are of most value to the local markets, so please do provide your feedback so that we can improve
this offering.
What does a Content Pack cost? Subject to approval, the creation of Global Content Packs will be funded through the Spend Smart for
Growth (SS4G) initiative. Your GDO Engagement Director will discuss with you what can be included in a
Content Pack.
For local markets, you can contact your GDO Regional Engagement Team member to learn more about
the cost of localising a Content Pack asset.
For more information on the SS4G Initiative, see the SS4G section of the Content Centre Terminology
Document.
How long does it take to prepare a Global Content Pack? The overall time will depend on the types of assets selected to form a Content Pack. The benefit of
Content Packs is that the overall time get Content Packs to a local market will be significantly shorter than
leaving local markets to build content on their own, as well as providing local markets with cost benefits,
and ensuring strategic alignment.
Are Content Packs globally approved? Yes. All the assets produced as part of Content Packs have been reviewed by GPPS and have been
through the global approval process. However, as with all Content Centre assets, local review and
approval for use in market will also be required.
Where can I look at the Content Packs that are already available? Content Packs will be clearly identified in Content Centre with a Content Pack logo on the thumbnail of
each Content Pack asset. You will also be able to search using ”Content Pack” as a search term to see
all of the Content Packs that are currently available.
How do I know what other Content Packs are coming? The Content Centre Calendar will show which Content Pack assets will be available and when.
Additionally, the monthly Content Centre News Flash will alert you to new Content Pack assets. You may
also receive news directly from GPPS on their plans for Content Packs. Finally, an email notification can
be set up directly from the Content Centre. The Content Centre job aid (on the Content Centre Welcome
Page) provides instructions on how you can subscribe to email notifications or you can open “My Profile”
within Content Centre.
Please note that because Content Packs are a new offering from Content Centre, Content Packs will not
be available for all brands immediately. Content Packs will be created when GPPS has a new campaign
and plan to create or refresh an iDA or CVA. This will be a trigger for a Content Pack to be created.
Frequently Asked Questions
Please note: Local market Nom Sig approval is still needed prior to local market use. You must also verify that
AstraZeneca owns the rights to reuse these assets/components and any files that are part of them for the context, location, and duration of your intended use.
Last Edit: July 14, 2017 Page 14
What is the best way to localise the Content Pack assets? Global Digital Organisation (GDO) can help you to localise the Content Pack assets in a quick, efficient,
and cost effective way. Please speak to your GDO Regional Engagement Team member for more
information on this service.
Who can I talk to about working on and creating a Content Pack? If you work in GPPS, please contact the Global Engagement Director for your brand. They will be
delighted to talk to you about Content Packs and share with you the asset options available. If you are in
a market, please contact your GDO Regional Engagement Team member. They will help you with
Content Packs that already available or will take your feedback and use it to help shape future Content
Packs.
How do I access and download the Content Pack materials? Content Packs are clearly identified within Content Centre with a Content Pack logo located on the
thumbnail tile. You can also search using ‘Content Pack’ as a search term to see all the Content Pack
assets that are currently available. Once you see the Content Pack that you are interested in, you will
have the option to download the assets within it. You can either download a single asset or any number of
assets. A short training video is available within Content Centre to help you if you want to do a batch
(multiple asset) download. You can also contact Content Centre help if you are experiencing any issues.
Frequently Asked Questions
Please note: Local market Nom Sig approval is still needed prior to local market use. You must also verify that
AstraZeneca owns the rights to reuse these assets/components and any files that are part of them for the context, location, and duration of your intended use.
Last Edit: July 14, 2017 Page 15
Download Logistics
How long does it take to download the file? This inevitably varies with file size. However, AZ marketers will rarely need source files themselves, so
they can choose to download only a preview (often a .pdf or .mov) and send a link to their agency who
can download all the source files separately. Content Centre has implemented a file download
acceleration technology to ensure Content Centre downloads are as fast as currently possible within the
constraints of the local infrastructure. When a user receives an email notification that a download
package is available, the email will contain 2 links – one for the accelerated file download process and
one for the regular download process. The first time that the file accelerator process is used, a brief
installation process occurs; however, this is a one-time process.
Where do downloaded files end up? The user is required to select a file destination. The file name path cannot exceed 216 characters;
therefore, Content Centre recommends that you download files to your Desktop to limit the length of
the file name. However, this destination can be on a removable drive if required.
What do I need to download? Should I include associated files or not? In order to download only the preview files and not the complete package, please select “No” in
the Download Asset popup that is displayed after selecting the download option. This will be a
smaller, faster download package and will include all of the files needed to preview an asset.
In case you want to access the complete source files and associated documents, it is best to
select “Yes” to include associated files option. This download package is larger, but contains all of
the source files, reference lists, annotated citations, licenses, and global rights. After download,
please make sure you check the zip file in the Associated Files folder. This is where all the
source files are stored.
Can the associated source file download option be made default? The default option is currently not an option at the user level. In order to download source files, the user
needs to select “YES” for the “include associated files” option.
Are the reference documents present on Validated Assets? For copyright reasons, Content Centre downloads do not include PDF copies of reference documents.
However, all Validated Assets come with a fully referenced English language manuscript with annotated
citations. These annotated citations include page number and paragraph number so that anyone with a
PDF of the reference can see exactly where in the publication the reference is located. All reference
documents may be viewed within the global approval tool; however, these documents are not available
for download due to copyright restrictions.
Frequently Asked Questions
Please note: Local market Nom Sig approval is still needed prior to local market use. You must also verify that
AstraZeneca owns the rights to reuse these assets/components and any files that are part of them for the context, location, and duration of your intended use.
Last Edit: July 14, 2017 Page 16
Support
Who are the local Production Partners? There are several Preferred Production Partners to support the localisation and translation of content.
Contact the GDO Engagement Team in your area.
Is Content Centre going to make any content changes for the assets? Content Centre is responsible for the validation of the asset and for the HTML coding of iDAs, not the
content itself. Content is the responsibility of the global team. Content Centre will only make changes that
the global team or a localising market requests.
If the local marketing teams need help purchasing fonts, who do they reach
out to? If the fonts have not been purchased globally, then the local agency would buy the fonts on behalf of the
local markets. The details for purchase will be in the MRF as well as the Usage Rights Information section
on the Content Centre.
What other services does Content Centre provide? Content Centre can assist with testing and uploading of learning content on both the GCA Portal and
AZLearn. In addition, Content Centre can help add learners to your curriculum and provide you with
reporting. A special team named GDO Global Learning Services has been created to assist you with
these activities. Please reach out to them directly at [email protected].
Frequently Asked Questions
Please note: Local market Nom Sig approval is still needed prior to local market use. You must also verify that
AstraZeneca owns the rights to reuse these assets/components and any files that are part of them for the context, location, and duration of your intended use.
Last Edit: July 14, 2017 Page 17
Training
Who do I contact if I have questions? There are multiple ways to get Content Centre information and support from GDO:
Global Engagement Team
Contact the Content Centre mailbox [[email protected]]
Post a message in the Content Centre Chatter Group
For access to Content Centre platform send requests to: [email protected]
For assistance with the GCA Portal and SCLA developed learning content, contact
What Content Centre training will be provided and when? Content Centre offers eLearning modules for a variety of audiences. To view the offerings, please check
the Content Centre Welcome Page. If you are interested in additional information after completing the
training, please contact the Content Centre mailbox ([email protected]). Please note that
modules are hosted in AZ Learn. If you need access to AZ Learn, please contact the Content Centre
Mailbox ([email protected]).
Are agencies able to take eLearning modules? Yes, agencies are required to complete Content Centre training modules listed on the Content Centre
Welcome Page. Modules are hosted in AZ Learn. If you need access to AZ Learn, please contact the
Content Centre Mailbox ([email protected]).
Top Related